Abstract
Spleen cell populations from mice treated with Adriamycin or daunorubicin were found to develop a greater PHA-stimulated clonal response than spleen cells from untreated or cyclophosphamide-treated animals. Daunorubicin, in addition, stimulated an unusual monocytic macrophage-like colony. The results are consistent with the possibility that the concentration of nonspecific T-lymphocyte progenitor and/or accessory cells in the spleen are increased consequent to drug treatment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
